Affordable Access

deepdyve-link
Publisher Website

Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL.

Authors
  • Picardi, Marco1
  • Della Pepa, Roberta2
  • Giordano, Claudia2
  • Zacheo, Irene2
  • Pugliese, Novella2
  • Mortaruolo, Chiara2
  • Trastulli, Fabio2
  • Giordano, Antonio2
  • Lucignano, Mariano2
  • Di Perna, Maria2
  • Raimondo, Marta2
  • Salvatore, Claudia3
  • Pane, Fabrizio2
  • 1 Department of Advanced Biomedical Sciences and.
  • 2 Department of Clinical Medicine and Surgery, Federico II University Medical, School, Naples, Italy; and. , (Italy)
  • 3 Department of Economics, University of Molise, Campobasso, Italy. , (Italy)
Type
Published Article
Journal
Blood
Publisher
American Society of Hematology
Publication Date
Jan 31, 2019
Volume
133
Issue
5
Pages
498–501
Identifiers
DOI: 10.1182/blood-2018-10-878892
PMID: 30530802
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times